Linguo Xie

Papers

Total Citations

H-Index

About

Dr. Linguo Xie is a leading figure in urologic oncology, with a primary research focus on minimally invasive surgical techniques for renal cell carcinoma. His most impactful work centers on the comparative effectiveness of robot-assisted partial nephrectomy (RAPN) versus traditional open surgery. In his landmark 2016 systematic review and meta-analysis, cited over 50 times, Dr. Xie provided critical evidence demonstrating that RAPN offers comparable oncologic safety to open partial nephrectomy while significantly reducing perioperative morbidity, including lower blood loss and shorter hospital stays. This seminal work has helped guide clinical decision-making and accelerate the global adoption of robotic surgery for kidney cancer. Beyond this core contribution, Dr. Xie’s research portfolio explores broader innovations in surgical oncology, aiming to optimize patient outcomes through evidence-based evaluation of emerging technologies. His rigorous meta-analytical approach has established a foundation for future prospective trials, solidifying his reputation as a key voice in the evolution of nephron-sparing surgery.